November 29 , 2021
1017 days
583
- ITC is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.
- It is developed by scientists at ITC Life Sciences and Technology Centre (LSTC), Bengaluru.
- The company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals.
![](https://www.tnpscthervupettagam.com/assets/home/media/general/original_image/29-130.jpg)
Post Views:
583